Priser
Platform
Blog
Om os
Download
NAPCO Security Technologies
NAPCO Security Technologies
Nasdaq
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NAPCO SECURITY TECHNOLOGIES MED ENDAVU: Køb NAPCO Security Technologies ($NSSC) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NAPCO Security Technologies, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Adimmune Corp is a biotechnology company focusing on the research, production, and distribution of vaccines. Established as a significant player within the pharmaceutical industry, its primary function is to develop vaccines that contribute to public health by preventing infectious diseases. The company is involved in producing seasonal influenza vaccines and is active in research for innovative vaccine solutions to tackle emerging health threats. Additionally, Adimmune Corp extends its operations to contract manufacturing services for other pharmaceutical companies, utilizing its advanced production facilities. The corporation plays a crucial role in the healthcare sector by ensuring the availability of critical vaccines, thus supporting global health initiatives. With a commitment to maintaining high-quality standards and deploying cutting-edge technology, Adimmune Corp is essential to the global supply chain for vaccines, thereby contributing to the mitigation of disease spread and the promotion of public health on an international scale.

Information

Ticker4142
Land
Taiwan
Hjemmesideadimmune.com.tw
SektorSundhed
IndustriBioteknologi

Udbytter

0,5TWD
'21
Ex-udbytte-dato14. sep. 2021
Udbytteafkast0%

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
100%0%0%0%0%